Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PLASMACON N, PLASMACON L-1, PLASMACON L-2

K-Number: K062306 · 2007-03-16

ApplicantR2 Diagnostics, Inc.
Decision Date2007-03-16
Product CodeGGC
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

PLASMACON N, PLASMACON L-1, PLASMACON L-2 is the device name listed in this FDA 510(k) record. The listed applicant is R2 Diagnostics, Inc.. It received FDA 510(k) clearance on 2007-03-16 under 510(k) number K062306. The device is classified under product code GGC. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PLASMACON N, PLASMACON L-1, PLASMACON L-2?

PLASMACON N, PLASMACON L-1, PLASMACON L-2 is a medical device that received FDA 510(k) clearance on 2007-03-16. The listed applicant is R2 Diagnostics, Inc.. The 510(k) number is K062306.

When did PLASMACON N, PLASMACON L-1, PLASMACON L-2 receive FDA 510(k) clearance?

PLASMACON N, PLASMACON L-1, PLASMACON L-2 received FDA 510(k) clearance on 2007-03-16, under 510(k) number K062306.

Who is the listed applicant for PLASMACON N, PLASMACON L-1, PLASMACON L-2?

The FDA 510(k) record lists R2 Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PLASMACON N, PLASMACON L-1, PLASMACON L-2?

The FDA product code for PLASMACON N, PLASMACON L-1, PLASMACON L-2 is GGC.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing R2 Diagnostics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K102908NOFACT IXK102851NOFACT VIIIK090105LUPOTEK KCTK083878LUPOTEK CORRECTIN VL, LUPOTEK DETECTIN VL, PLASMACON LAK082631THROMBO TEK PSE, MODEL 90-480K050817T-TEK

View all 10 devices →

Related Devices (Code: GGC)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K102552HEMOSIL LA POSITIVE CONTROLInstrumentation Laboratory COK100103SPECIALTY ASSAYED CONTROL-2Helena LaboratoriesK061803STA - CONTROL LA 1+2Diagnostica Stago, Inc.K032804CRYOCHECK WEAK LUPUS POSITIVE CONTROLPrecision BiologicK023312CONTROL PLASMA PDade Behring, Inc.K020878LYPHOCHEK HEMOSTASIS, MODELS 798, 799Bio-Rad

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑